MYDA Advisors’s Oracle ORCL Stock Holding History

MYDA Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$8.72M	–	252
2021 Q4	$8.72M	Buy	+100,000	New	+$9.39M	2.33%	4

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MYDA Advisors's ORCL Position: Q1 2022 in Review

MYDA Advisors sold out of Oracle (ORCL) in Q1 2022, closing a stake of 100,000 shares — an estimated $8.72M sold.

MYDA Advisors first reported a position in ORCL in Q4 2021 and held it in 1 quarter. The position peaked at $8.72M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold ORCL as of Q1 2022.

MYDA Advisors reported no remaining Oracle position as of Q1 2022 after selling out during the quarter.
MYDA Advisors sold 100,000 Oracle shares in Q1 2022, an estimated $8.72M.
MYDA Advisors first reported a position in Oracle in Q4 2021 and held it in 1 quarter.
MYDA Advisors's Oracle position peaked at $8.72M in Q4 2021.
2,266 funds tracked by Wall St. Rank held Oracle as of Q1 2022.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.